SciSparc rises after deal to buy Xylo's medical device patents

Scisparc

26/11/2025 17:57

Updates

** Shares of Israel-based drug developer SciSparc SPRC.O rise 13.5% to $2.76

** Co says it has agreed to buy portfolio of patents and intellectual property for medical devices from Xylo Technologies

** Deal includes "MUSE system," a single-use endoscopic device used in minimally invasive procedure to treat acid reflux disease, known as GERD

** Xylo to get 19.99% of SPRC's share capital or pre-funded warrants at closing, co says

** Co says it plans to replicate Xylo's China commercialization model in North America, Europe and Latin America

** Including session's move, stock down ~63% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))